Unless we have people in charge of the FDA who really care about consumer health and safety, you can’t rely on this government agency to protect you. Obama’s appointment to head the FDA has been the subject of fierce criticism for his ties to industry. Read full article here.
Dr. Robert Califf, President Obama’s nominee to head the Food and Drug Administration, has been the target of serious criticism in recent weeks over his close ties to the pharmaceutical industry. He has received hundreds of thousands of dollars from Big Pharma. Furthermore, his prestigious post at Duke University was underwritten by some of the biggest names in the industry, including Bristol-Meyer Squibb, Eli Lily, Merck and Novartis. Now, there are new questions being raised over a clinical trial that was overseen by Califf in 2011.
Comments for this article are closed.